CINECA IRIS Institutional Research Information System

MANERA, Umberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.018
EU - Europa 2.401
AS - Asia 880
SA - Sud America 36
OC - Oceania 29
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.382
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.965
IT - Italia 1.033
CN - Cina 447
IE - Irlanda 307
SE - Svezia 226
FR - Francia 132
AT - Austria 130
DE - Germania 128
SG - Singapore 112
GB - Regno Unito 91
FI - Finlandia 86
IN - India 64
VN - Vietnam 63
JP - Giappone 57
KR - Corea 48
ES - Italia 45
CA - Canada 42
UA - Ucraina 40
BE - Belgio 34
NL - Olanda 34
BR - Brasile 25
PL - Polonia 24
AU - Australia 22
GR - Grecia 20
UZ - Uzbekistan 17
HK - Hong Kong 16
TR - Turchia 16
MX - Messico 10
PT - Portogallo 10
CH - Svizzera 9
RU - Federazione Russa 9
TW - Taiwan 8
BG - Bulgaria 7
NZ - Nuova Zelanda 7
CO - Colombia 6
DK - Danimarca 6
PH - Filippine 6
RO - Romania 6
CZ - Repubblica Ceca 5
EG - Egitto 5
ID - Indonesia 5
BY - Bielorussia 4
EU - Europa 4
IR - Iran 4
SN - Senegal 4
TH - Thailandia 4
AL - Albania 3
HR - Croazia 3
IL - Israele 3
IQ - Iraq 3
NO - Norvegia 3
AR - Argentina 2
BD - Bangladesh 2
CL - Cile 2
MU - Mauritius 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
CR - Costa Rica 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 6.382
Salva come PNG Salva come JPEG
Città #
Chandler 546
Dublin 304
Beijing 184
Torino 171
Ashburn 149
Vienna 128
Fairfield 127
Ann Arbor 116
Nyköping 106
Houston 98
Turin 92
Medford 77
Milan 76
Redwood City 76
Wilmington 74
Princeton 70
Jacksonville 68
Seattle 67
Singapore 64
Woodbridge 56
Villeurbanne 52
Cambridge 51
Fremont 51
Lappeenranta 44
Rome 39
Dearborn 35
Pisa 33
Dong Ket 27
Chengdu 26
Hangzhou 26
Brussels 24
Boston 22
New York 22
Boardman 21
Warsaw 21
Santa Monica 20
Shanghai 18
Toronto 17
Seoul 16
London 15
Norwalk 15
Zhengzhou 12
Hebei 11
Moncalieri 11
Nanjing 11
San Diego 11
Bologna 10
Cervignano Del Friuli 10
Chicago 10
Guangzhou 10
San Mauro Torinese 10
Padova 9
Washington 9
Atlanta 8
Bari 8
Cagliari 8
Dronten 8
Hefei 8
Helsinki 8
Los Angeles 8
Nanchang 8
Naples 8
Nürnberg 8
Barcelona 7
Carugate 7
Falls Church 7
Florence 7
Grugliasco 7
Malmö 7
Pune 7
Upper Marlboro 7
Verona 7
Amsterdam 6
Baltimore 6
Bengaluru 6
Chennai 6
Genova 6
Guiyang 6
Hong Kong 6
Limoges 6
Munich 6
Ottawa 6
Palermo 6
Paris 6
San Francisco 6
Santa Clara 6
Siena 6
Silver Spring 6
Taipei 6
Taranto 6
Tokyo 6
Cisano Bergamasco 5
Dugenta 5
Jakarta 5
Kunming 5
Mountain View 5
New Delhi 5
Parma 5
Phoenix 5
Sheffield 5
Totale 3.670
Salva come PNG Salva come JPEG
Nome #
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 590
A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study 415
Validation of the revised classification of cognitive and behavioural impairment in ALS 238
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 228
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 202
Validation of the Italian version of self-administered ALSFRS-R scale 201
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 172
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 150
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 148
The multistep hypothesis of ALS revisited: The role of genetic mutations 142
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 134
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 131
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 130
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 122
Influence of cigarette smoking on ALS outcome: A population-based study 122
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 119
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 114
Cognitive impairment across ALS clinical stages in a population-based cohort 106
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 104
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 99
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 91
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 87
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 86
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 82
NADPH oxidases 2 activation in patients with Parkinson's disease 81
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 80
Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study. 75
EXECUTIVE DYSFUNCTION SCORE OF THE FRONTAL BEHAVIOR SYSTEM SCALE (FrSBe) IS INDEPENDENTLY RELATED TO ALS OUTCOME 74
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study 67
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 66
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 65
ALS phenotype is influenced by age, sex, and genetics: A population-based study 64
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 64
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes 63
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic 61
Genetic architecture of ALS in Sardinia. 59
Differential neuropsychological profile of ALS patients with and without C9orf72 mutation 59
The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis 58
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 56
Alcohol consumption and the risk of amyotrophic lateral sclerosis 55
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study 54
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience 54
Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study 53
Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis 51
Comorbidity of Cervical Spondylogenic Myelopathy and Amyotrophic Lateral Sclerosis: When Electromyography Makes the Difference in Diagnosis 51
Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study 50
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 50
GBA variants influence cognitive status in amyotrophic lateral sclerosis 50
A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation 49
Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study 49
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis 49
Friedreich's ataxia patients and caregivers information seeking behaviour 48
Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud 46
A novel splice site FUS mutation in a familial ALS case: effects on protein expression 46
Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 42
Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers 40
Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort 39
Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis 39
The characteristics of cognitive impairment in als patients depend on the lateralization of motor damage 38
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment 35
Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia 35
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 34
Prognostic role of slow vital capacity in amyotrophic lateral sclerosis 34
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 31
What is amyotrophic lateral sclerosis prevalence? 31
Causal associations of genetic factors with clinical progression in amyotrophic lateral sclerosis 30
Social Cognition deficits in Amyotrophic Lateral Sclerosis: a pilot cross-sectional population-based study 29
Deep learning methods to predict amyotrophic lateral sclerosis disease progression 27
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 22
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 22
SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients 21
Brain 18fluorodeoxyglucose-positron emission tomography changes in amyotrophic lateral sclerosis with TARDBP mutations 20
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 18
Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis 18
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 17
Factors predicting disease progression in C9ORF72 ALS patients 17
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol 16
Respiratory support in a population-based ALS cohort: demographic, timing and survival determinants 16
Serum chloride as a respiratory failure marker in amyotrophic lateral sclerosis 15
Systematic evaluation of genetic mutations in ALS: a population-based study 15
Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review 14
Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis 14
Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis 14
Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study 13
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 12
Can amyotrophic lateral sclerosis progression really pause? A cohort study using the medical research council scale 11
Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis 10
C9orf72 ALS mutation carriers show extensive cortical and subcortical damage compared to matched wild-type ALS patients 10
The role of peripheral immunity in ALS: a population-based study 9
High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis 7
Mycotoxins and Amyotrophic Lateral Sclerosis: food exposure, nutritional implications and dietary solutions 6
Calculated Maximal Volume Ventilation (cMVV) as a Marker of Early Respiratory Failure in Amyotrophic Lateral Sclerosis (ALS) 6
High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants 4
Resting-state fMRI functional connectome of C9orf72 mutation status 4
Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the TARDBP Pathogenic Variant 4
Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries 3
A mother and her daughter carrying a pathogenic expansion of the HTT gene with a phenotype encompassing motor neuron disease and Huntington's disease 3
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis 3
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosis 2
Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers 2
Totale 6.612
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.683
article - articoli 0
book - libri 0
conference - conferenze 1.521
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201948 0 0 0 0 0 0 0 0 0 0 0 48
2019/2020668 23 29 34 52 24 75 75 74 95 104 43 40
2020/2021844 47 61 53 41 57 69 75 93 127 69 33 119
2021/20221.078 51 17 58 87 79 74 67 53 55 92 263 182
2022/20231.668 182 153 41 127 159 390 109 107 181 63 95 61
2023/20241.220 156 185 85 72 78 117 92 72 18 117 104 124
Totale 6.612